Improving access to affordable quality-assured inhaled medicines in LMICs

This article summarizes the discussions at stakeholder meeting convened by the International Union Against Tuberculosis and Lung Disease in February 2022. The output was a multi-stakeholder action plan to improve access to affordable, quality-assured inhaled medicines, with actions relating to: awareness, clinical guidance, supply chain, data, communications and WHO.